NXGL NEXGEL, Inc.
Healthcare$0.53-2.59%ClosedMarket Cap: $4.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.11
P/S
0.44
EV/EBITDA
-3.07
DCF Value
$-266.03
FCF Yield
-28.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.9%
Operating Margin
-31.4%
Net Margin
-28.5%
ROE
-70.2%
ROA
-27.7%
ROIC
-40.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.6M | 40.0% | $-958.0K | $-927.0K | $— | — |
| Q4 null | $2.8M | 29.3% | $-1.2M | $-970.0K | $— | — |
| FY null | $11.4M | 39.5% | $-3.4M | $-3.0M | $— | — |
| Q3 null | $2.9M | 42.4% | $-725.0K | $-653.0K | $— | — |
| Q2 null | $2.9M | 43.6% | $-636.0K | $-665.0K | $— | — |
| Q1 null | $2.8M | 42.3% | $-777.0K | $-712.0K | $— | — |
| Q4 null | $3.0M | 25.6% | $-841.0K | $-850.0K | $— | — |
| FY null | $8.7M | 31.6% | $-3.6M | $-3.3M | $— | — |
| Q3 null | $2.9M | 43.6% | $-788.0K | $-693.0K | $— | — |
| Q2 null | $1.4M | 28.5% | $-1.1M | $-885.0K | $— | — |
| Q1 null | $1.3M | 12.6% | $-871.0K | $-853.0K | $— | — |
| Q4 2023 | $1.1M | 14.6% | $-1.2M | $-1.1M | $-0.19 | — |